
Velcade 1mg Injection
Marketer
Janssen Pharmaceuticals
Salt Composition
Bortezomib (1mg)
Overview Velcade 1mg Injection
Bortezomib 1mg injection is indicated for multiple myeloma and mantle cell lymphoma treatment. Its mechanism involves inhibiting or slowing cancerous cell proliferation. Administration is via injection by a healthcare professional. Dosage and frequency are determined by your physician, varying based on your condition and potentially adjusted over time. Strict adherence to your doctor's instructions is crucial, as incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include fatigue, nausea, vomiting, and decreased appetite. Increased fluid intake is often recommended. Operating machinery or driving may be impaired due to potential drowsiness and dizziness. This medication can reduce blood cell counts (red and white blood cells), raising infection risk. Regular blood tests monitoring blood cell levels, along with heart, liver function, and uric acid are necessary. Pre-existing liver, kidney, heart conditions, or bleeding disorders should be disclosed to your doctor before initiating treatment. Report any cognitive symptoms like memory impairment or difficulty concentrating. Inform your healthcare provider about all other medications you are taking, as interactions are possible. Use during pregnancy or breastfeeding is contraindicated; effective contraception for both partners is essential. A patient support/assistance program exists in India, managed by Tata 1mg; contact your physician or call (1800-102-1618) for more information.
Uses of Velcade 1mg Injection
Myeloma and mantle cell lymphoma
Major Benefits of Velcade 1mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Velcade 1mg Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Velcade 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Velcade 1mg Injection works:
Bortezomib 1mg injection is a cancer therapy that inhibits the cellular breakdown of specific proteins. This accumulation of proteins within cancerous cells ultimately triggers their demise.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption can increase the sedative effects of a 1mg Velcade injection.
PregnancyCONSULT YOUR DOCTOR
Administering Velcade 1mg Injection during pregnancy carries a confirmed risk to the fetus. Its use is contraindicated except in rare, life-threatening circumstances where the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Breastfeeding is contraindicated while using Velcade 1mg Injection due to the potential for infant toxicity.
DrivingUNSAFE
Administering Velcade 1mg Injection may induce adverse reactions impacting driving capabilities. These reactions can include fatigue, vertigo, syncope, or visual disturbances, potentially compromising safe driving.
KidneyCAUTION
Caution is advised when administering Velcade 1mg Injection to individuals with significant renal impairment. Dosage modification of Velcade 1mg Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Velcade 1mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Velcade 1mg Injection :
Omit a Velcade 1mg Injection dose? Seek your physician's advice.
Facts to Know About Velcade 1mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylalanine-based Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
